This is a EndoMT news story, published by IMR Press, that relates primarily to LPS news.
For more EndoMT news, you can click here:
more EndoMT newsFor more disease research news, you can click here:
more disease research newsFor more news from IMR Press, you can click here:
more news from IMR PressOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
endothelial inflammation. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Endothelial news, endothelial traits news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
endothelial cellsIMR Press
•76% Informative
Lipolysaccharide ( LPS ) was administered intraperitoneally to mice several times to establish a chronic inflammatory model.
A cellular inflammatory model was established by LPS in human brain microvascular endothelial cells.
The knockdown of Sestrin2 in HBMECs exacerbated the EndoMT .
VR Score
82
Informative language
87
Neutral language
52
Article tone
formal
Language
English
Language complexity
87
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links